ArticleWorld journal of urology2026
Stress urinary incontinence and sarcopenia in postmenopausal osteoporosis: the intersection of muscle loss and pelvic dysfunction.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06655701 (Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis: The Intersection of Muscle Loss and Pelvic Dysfunction
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to investigate the relationship between sarcopenia and stress urinary incontinence (SUI) in postmenopausal women with and without osteoporosis and to identify independent predictors of SUI.
methodsThis cross-sectional study included 100 postmenopausal women aged 60–75 years, with 50 osteoporotic and 50 non-osteoporotic participants based on DXA T-scores. Sarcopenia was diagnosed using EWGSOP2 criteria. Muscle strength was assessed by handgrip and chair stand tests, and muscle mass was measured via bioelectrical impedance analysis. The presence of SUI was determined by self-reported symptoms. The impact of UI on quality of life was assessed using the Incontinence Quality of Life Questionnaire (I-QOL).
resultsSarcopenia was more prevalent in the osteoporotic group than in controls (30% vs. 12%, p = 0.027). SUI was also more common among osteoporotic patients (50% vs. 24%, p = 0.013). In the osteoporosis group, probable sarcopenia was more frequent in women with SUI than in those without SUI (72% vs. 40%, p = 0.023), while the prevalence of definite sarcopenia did not differ significantly. In multivariate logistic regression, osteoporosis (OR = 3.519, 95% CI: 1.213–10.211, p = 0.021) and sarcopenia (OR = 3.313, 95% CI: 1.112–9.868, p = 0.031) were both significantly associated with SUI. No significant association was found between SUI and age, BMI, comorbidities, number of vaginal deliveries, or constipation. I-QOL scores were positively correlated with handgrip strength and negatively correlated with chair stand duration.
conclusionSarcopenia and SUI were more prevalent in postmenopausal women with osteoporosis. Both osteoporosis and sarcopenia were independent risk factors for SUI. These findings highlight the importance of assessing muscle strength and pelvic floor function in postmenopausal women, particularly those with osteoporosis. CLINICAL TRIALS: ClinicalTrials.gov ID: NCT06655701.
Indexed as
Identifiers
41935994What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.